Skip to main content


Diabetes Therapy

Research, treatment and education of diabetes and related disorders

Diabetes Therapy OnlineFirst articles

11.07.2020 | Original Research Open Access

Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach

Uncontrolled diabetes mellitus (DM) is characterized by deviations in insulin secretion/action, affecting glucose metabolism with important consequences for the patient’s overall health and quality of life. DM is a major cause of cardiovascular …

10.07.2020 | Original Research Open Access

Persistence with Basal Insulin and Frequency of Hypoglycemia Requiring Hospitalization in Patients with Type 2 Diabetes

Due to the progressive nature of type 2 diabetes (T2DM), initiation of treatment with insulin is a necessary step towards achieving optimal glycemic targets. It is well established that an adequate glycemic control reduces diabetes-related …

10.07.2020 | Review Open Access

Why Do Falls and Lower Limb Fractures Occur More Frequently in the Diabetic Patient and How Can They Be Prevented?

Due to primarily sarcopenia and hypoglycemia but also neuropathy, hypotension, analgesics and polypharmacy, there is an increased incidence of falls and hip fractures in both the type 1 and type 2 diabetic patient. Utilization of insulin …

09.07.2020 | Original Research Open Access

Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials

A frequently underappreciated comorbidity of type 2 diabetes mellitus (T2DM) is non-alcoholic fatty liver disease (NAFLD), with a global prevalence of 55.5% among patients with T2DM [ 1 ]. Patients with NAFLD are usually asymptomatic and are often …

08.07.2020 | Original Research Open Access

Patient-Reported Outcomes with Insulin Glargine 300 U/mL in People with Type 2 Diabetes: The MAGE Multicenter Observational Study

Improving treatment satisfaction and safety are important for treating type 2 diabetes (T2DM) and are required to gain better treatment adherence, thereby improving long-term outcomes [ 1 ]. Poor adherence to insulin treatment results from many …

Aktuelle Ausgaben

Über diese Zeitschrift

Diabetes Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of diabetes therapies. Studies relating to diagnosis, devices and diabetes technology, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, and short communications. The journal appeals to a global audience and receives submissions from all over the world.

Moving forward from traditional publishing, Diabetes Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are open access and are peer reviewed to the same high standard as the article itself.

Diabetes Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here:

Upon acceptance of your article for publication, you will be required to pay the article processing charge of £230/$360 per printed page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access.

For more information about the journal, please contact or see the News page for the latest journal offers.

Weitere Informationen

Neu im Fachgebiet Innere Medizin

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin